These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6233994)

  • 81. [Drugs news].
    Autret-Leca E
    Arch Pediatr; 2010 Nov; 17(11):1596-603. PubMed ID: 20719481
    [No Abstract]   [Full Text] [Related]  

  • 82. [Therapeutic contra-indications].
    Cah Coll Med Hop Paris; 1969 Dec; 10(17):1463-5. PubMed ID: 5378396
    [No Abstract]   [Full Text] [Related]  

  • 83. [Sense and nonsense of drug therapy].
    Buess H
    Z Krankenpfl; 1973 Nov; 66(11):415-7. PubMed ID: 4492021
    [No Abstract]   [Full Text] [Related]  

  • 84. Drugs and the elderly: a breeding-ground for mishaps.
    Bishop T
    Nurs Mirror; 1978 Nov; 147(21):49-50. PubMed ID: 251305
    [No Abstract]   [Full Text] [Related]  

  • 85. Mianserin product licence.
    Brahams D
    Lancet; 1989 Feb; 1(8635):452. PubMed ID: 2563838
    [No Abstract]   [Full Text] [Related]  

  • 86. RXWriter and Medication Manager.
    Epinette WW
    MD Comput; 1987; 4(2):29-32. PubMed ID: 3574037
    [No Abstract]   [Full Text] [Related]  

  • 87. [An evaluation of routines for drug handling in homes for the aged].
    Hunskår S; Sommersten AM
    Tidsskr Nor Laegeforen; 1988 Mar; 108(8-9):665-6. PubMed ID: 3353966
    [No Abstract]   [Full Text] [Related]  

  • 88. [Clinical pharmacology and clinical evaluation of drugs. Significance and progress].
    Böger RH; Darius H
    Internist (Berl); 2002 Apr; 43(4):459. PubMed ID: 12053401
    [No Abstract]   [Full Text] [Related]  

  • 89. Medication hazards in dentistry. I.
    Kay LW
    J Ir Dent Assoc; 1972; 18(5):209-17. PubMed ID: 4509919
    [No Abstract]   [Full Text] [Related]  

  • 90. Drug interactions of clinical importance. An updated guide.
    Quinn DI; Day RO
    Drug Saf; 1995 Jun; 12(6):393-452. PubMed ID: 8527014
    [No Abstract]   [Full Text] [Related]  

  • 91. [Off label prescriptions: from creativity to rigour].
    Revuz J
    Ann Dermatol Venereol; 2004; 131(8-9):761-3. PubMed ID: 15505540
    [No Abstract]   [Full Text] [Related]  

  • 92. Introduction to pharmacoepidemiology.
    Hartzema AG; Porta MS; Tilson HH
    Drug Intell Clin Pharm; 1987 Sep; 21(9):739-40. PubMed ID: 3652936
    [No Abstract]   [Full Text] [Related]  

  • 93. Evaluating therapeutic accomplishments.
    Pulliam CC
    Am J Hosp Pharm; 1974 Sep; 31(9):880-3. PubMed ID: 4424991
    [No Abstract]   [Full Text] [Related]  

  • 94. Drugs, cameras, and cars.
    Lancet; 1972 Sep; 2(7779):695. PubMed ID: 4115830
    [No Abstract]   [Full Text] [Related]  

  • 95. A comparative evaluation of drug interaction publications.
    Bell JE
    Am J Hosp Pharm; 1971 Dec; 28(12):938-44. PubMed ID: 5135188
    [No Abstract]   [Full Text] [Related]  

  • 96. [Drug prescriptions: anticipating interactions].
    Diquet B; Acker I; Lainé-Cessac P
    Rev Prat; 2011 Apr; 61(4):547-8. PubMed ID: 21548242
    [No Abstract]   [Full Text] [Related]  

  • 97. On the quantitative evaluation of pharmacologic agents.
    Jardetzky O
    J New Drugs; 1966; 6(4):203-7. PubMed ID: 5968053
    [No Abstract]   [Full Text] [Related]  

  • 98. Humanised science in evaluating medication.
    Lancet; 1972 Sep; 2(7777):595-6. PubMed ID: 4115758
    [No Abstract]   [Full Text] [Related]  

  • 99. [Drug surveillance in patients of advanced-age].
    Bol Oficina Sanit Panam; 1984 Apr; 96(4):342-52. PubMed ID: 6233994
    [No Abstract]   [Full Text] [Related]  

  • 100. Evaluating drugs after their approval for clinical use.
    Ray WA; Griffin MR; Avorn J
    N Engl J Med; 1993 Dec; 329(27):2029-32. PubMed ID: 8018139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.